Literature DB >> 3341767

A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets.

Y N Huo1, J Ekholm, D J Hanahan.   

Abstract

Zinc ions at micromolar levels exhibited a significant inhibitory activity toward platelet activating factor (AGEPC)- and thrombin-induced serotonin release from washed rabbit platelets. In the ranges from 25 to 30 microM and 10 to 50 microM, respectively, zinc essentially prevented any serotonin release from 1.25 X 10(8) cells/microliter by 1 X 10(-10) M AGEPC and by 0.2 unit thrombin/ml. This inhibition by zinc ions, in micromolar range, occurred in the presence of 1.0 mM Ca2+. The amount of zinc needed for inhibition was inversely proportional to the amount of AGEPC present and further zinc must be added prior to or at the same time as the AGEPC to be effective. Introduction of zinc ions after the AGEPC essentially abolished the inhibitory properties of this divalent cation. Other cations such as Cu2+, La3+, Cd2+, and Mg2+ were ineffective as inhibitors at concentrations where zinc showed its maximal effects. Under conditions similar to those noted above, aggregation induced by AGEPC was blocked only to the extent of 25% of a control. No inhibitory action by zinc on thrombin-induced aggregation was noted. It is apparent that zinc ions influence a site(s) on the rabbit platelet of considerable importance to the activation (or signaling) process by AGEPC and thrombin in these cells, as expressed by serotonin release. Zinc should provide a suitable probe to explore the mechanism of action of these agonists in their interaction with sensitive cells and to define in more specific biochemical terms the putative receptor for these molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341767     DOI: 10.1016/0003-9861(88)90515-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Quantitation by radioimmunoassay of PAF in human saliva.

Authors:  S J Cooney; M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 2.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

3.  Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.

Authors:  Alexandros B Tsoupras; Maria Roulia; Eleftherios Ferentinos; Ioannis Stamatopoulos; Constantinos A Demopoulos; Panayotis Kyritsis
Journal:  Bioinorg Chem Appl       Date:  2010-06-28       Impact factor: 7.778

4.  Zinc monoglycerolate: a slow-release source of zinc with anti-arthritic activity in rats.

Authors:  M W Whitehouse; K D Rainsford; R M Taylor; B Vernon-Roberts
Journal:  Agents Actions       Date:  1990-08

5.  Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2+).

Authors:  A Evangelou; V Kalfakakou; J Benveniste; B Arnoux
Journal:  Biol Trace Elem Res       Date:  1995-10       Impact factor: 3.738

6.  Synthesis of a PAF immunogen and production of PAF-specific antibodies.

Authors:  M A Smal; B A Baldo; J W Redmond
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

8.  Influence of a long-term zinc-deficient diet on rat platelet function and fatty acid composition.

Authors:  P Faure; P Durand; D Blache; A Favier; A M Roussel
Journal:  Biometals       Date:  1995-01       Impact factor: 2.949

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.